Literature DB >> 35130199

Combined VNS-RNS Neuromodulation for Epilepsy.

Pouya Khankhanian1, Angelica M Lee2, Cornelia N Drees3, Barbara M Decker4, Danielle A Becker3.   

Abstract

SUMMARY: The vagus nerve stimulator (VNS) and responsive nerve stimulator (RNS) are nonpharmacological devices approved for drug-resistant epilepsy. Vagus nerve stimulator was removed before placing an RNS in clinical trials. Two cases of bilateral mesial temporal epilepsy treated concurrently with VNS and bilateral mesial temporal RNS devices were reported. In each case, the VNS device was turned off temporarily, which allowed for a direct comparison of RNS recordings and efficacy with and without simultaneous VNS stimulation. Temporary VNS cessation lead to increased clinical and electrocorticographic seizures despite continued anti-seizure drugs and RNS stimulation. In one case, VNS eliminated seizures from one epileptogenic area, whereas VNS and RNS were required to treat seizures from the contralateral mesial temporal structure. In another case, VNS effectively decreased seizure spread to the symptomatogenic zone. These cases demonstrate synergistic neuromodulation with concurrent use of VNS and RNS in intractable bitemporal epilepsy.
Copyright © 2021 by the American Clinical Neurophysiology Society.

Entities:  

Mesh:

Year:  2022        PMID: 35130199      PMCID: PMC8822089          DOI: 10.1097/WNP.0000000000000870

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  7 in total

Review 1.  Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation.

Authors:  P Rutecki
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

2.  Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.

Authors:  Martha J Morrell
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

3.  Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

Authors:  G L Morris; W M Mueller
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

Review 4.  Comparison and Selection of Current Implantable Anti-Epileptic Devices.

Authors:  Stephen Wong; Ram Mani; Shabbar Danish
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

5.  Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Authors:  Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French
Journal:  Epilepsia       Date:  2009-11-03       Impact factor: 5.864

Review 6.  Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy.

Authors:  Chinekwu Anyanwu; Gholam K Motamedi
Journal:  Brain Sci       Date:  2018-03-21

7.  Practice trends and the outcome of neuromodulation therapies in epilepsy: A single-center study.

Authors:  Rabia Jamy; Manmeet Kaur; Diana Pizarro; Emilia Toth; Sandipan Pati
Journal:  Epilepsia Open       Date:  2019-06-11
  7 in total
  1 in total

Review 1.  Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy.

Authors:  Mohamed Abouelleil; Nachiket Deshpande; Rushna Ali
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.